Test Name	HOXB13 Gene Prostate cancer, familial, association with NGS Genetic DNA Test
Test type	Oncologist
Pre-test Information	Clinical History of Patient who is going for HOXB13 Gene Prostate cancer, familial, association with NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with HOXB13 Gene Prostate cancer, familial, association with NGS Genetic DNA Test gene HOXB13
Report Delivery	3 to 4 Weeks
Components
Price	₹ 20000
Method	NGS Technology

Short Description

NGS genetic DNA test detecets for variant and mutation detection in HOXB13 gene for Prostate cancer, familial, association with

PreTest Information

Clinical History of Patient who is going for HOXB13 Gene Prostate cancer, familial, association with NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with HOXB13 Gene Prostate cancer, familial, association with NGS Genetic DNA Test gene HOXB13

Detail Description

HOXB13 Gene Prostate Cancer: Familial Association with NGS Genetic DNA Test Cost INR 20,000

Prostate cancer is the most common cancer among men, and its incidence is increasing globally. It is estimated that 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Although most cases of prostate cancer are sporadic, some families have a higher risk of developing the disease due to inherited genetic mutations. One of the genes associated with familial prostate cancer is the HOXB13 gene. The HOXB13 gene provides instructions for making a protein that is involved in the development and growth of the prostate gland. Mutations in this gene have been linked to an increased risk of developing prostate cancer, particularly among men with a family history of the disease. NGS (Next Generation Sequencing) Genetic DNA testing is a powerful tool for identifying genetic mutations associated with familial prostate cancer. This type of testing analyzes multiple genes at once, providing a comprehensive analysis of an individual's genetic risk for prostate cancer. Symptoms of prostate cancer may include difficulty urinating, blood in the urine or semen, pain in the back, hips, or pelvis, and erectile dysfunction. However, many men with prostate cancer have no symptoms at all. Diagnosis of prostate cancer typically involves a combination of digital rectal examination (DRE), prostate-specific antigen (PSA) blood test, and biopsy. DRE involves a physician inserting a gloved finger into the rectum to feel for lumps or abnormalities in the prostate gland. The PSA blood test measures the level of a protein produced by the prostate gland. Elevated levels of PSA can indicate the presence of prostate cancer. A biopsy involves taking a small sample of prostate tissue and examining it under a microscope for the presence of cancer cells. NGS Genetic DNA testing for the HOXB13 gene and other genes associated with familial prostate cancer can provide valuable information for individuals and their families. The cost of this test in India is approximately INR 20,000. In conclusion, familial prostate cancer is linked to mutations in the HOXB13 gene. NGS Genetic DNA testing can help identify individuals at increased risk for prostate cancer, allowing for earlier detection and potentially life-saving interventions. If you are concerned about your risk for prostate cancer, talk to your healthcare provider about genetic testing options.

Before getting tested ask for Raw Data, FASTQ, and VCF files along with clinical test report from DNA Testing Lab. DNA Labs India is the Only lab that is transparent and will share Raw Data, FASTQ, and VCF files along with the conclusive clinical report for HOXB13 Gene Prostate cancer, familial, association with NGS Genetic DNA Test